Hospitalization and Survival in Patients Using Epoprostenol for Injection in the PROSPECT Observational Study

BACKGROUND: Few studies have prospectively reported outcomes in patients with pulmonary arterial hypertension (PAH) treated with epoprostenol in the modern-day era of oral therapy and combination treatments. The Registry to Prospectively Describe Use of Epoprostenol for Injection (Veletri, prolonged...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Chest
Auteurs principaux: Frantz, Robert P., Schilz, Robert J., Chakinala, Murali M., Badesch, David B., Frost, Adaani E., McLaughlin, Vallerie V., Barst, Robyn J., Rosenberg, Daniel M., Miller, Dave P., Hartline, Brian K., Benton, Wade W., Farber, Harrison W.
Format: Artigo
Langue:Inglês
Publié: American College of Chest Physicians 2015
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4314821/
https://ncbi.nlm.nih.gov/pubmed/25320967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1378/chest.14-1004
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires